Dendrimer–doxorubicin conjugate as enzyme-sensitive and polymeric nanoscale drug delivery vehicle for ovarian cancer therapy

Citations Over TimeTop 10% of 2014 papers

Abstract

Dendrimer–doxorubicin conjugate prepared via click chemistry was employed as enzyme-sensitive nanoscale drug delivery system for ovarian cancer therapy, showing high accumulation in tumor tissue, significantly increased antitumor activity and good biosafety.

Related Papers

• → The dendritic effect illustrated with phosphorus dendrimers(2014)129 cited
• Research on biosafety of transgenic plants.(2003)
• Laboratory Biosafety Principles and Practices(2013)
• Check and Assess of the Quality of Biosafety Cabinetry(2010)
• → Biosafety management in high-biosafety-risk workshops for vaccine production in China(2023)